Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 05, 2015 6:20 AM ET

Life Sciences Tools and Services

Company Overview of GATC Biotech AG

Company Overview

GATC Biotech AG provides DNA and RNA sequencing, and bioinformatics solutions to academic and industrial customers. The company sequences various bacterial, plant, and other whole genomes, as well as whole human genomes. It provides Sanger sequencing services, including SUPREMErun, a sequencing service for plasmids or PCR fragments; and LIGHTrun, a Sanger sequencing service for purified plasmids or PCR fragments. The company also offers InView Human Exome, a solution that provides faster variant detection for clinical research and translational studies; InView 1-Week Exome Diagnostic; InView Human Kinome; InView De novo Genome 2.0, a solution that facilitates the generation and bioinformatic...

Jakob-Stadler-Platz 7

Constance,  78467

Germany

Founded in 1990

Phone:

49 7531 81 60 0

Fax:

49 7531 81 60 81

Key Executives for GATC Biotech AG

Co-Founder, Chief Executive Officer and Director
Co-Founder, Chief Technology Officer and Director
Chief Operating Officer and Director
Head of Bioinformatics
Director Strategic Marketing & Corporate Communication
Compensation as of Fiscal Year 2015.

GATC Biotech AG Key Developments

Qiagen NV Partners with GATC Biotech to Offer Clients Full Access to Ingenuity

QIAGEN N.V. announced a commercial agreement with GATC Biotech to provide GATC clients full access to QIAGEN's Ingenuity Variant Analysis solution for analysis and interpretation of genetic data. The access will take the form of interpretation services and direct access to Ingenuity Variant Analysis as a feature of the GATC Biotech's services. Ingenuity Variant Analysis is a powerful bioinformatics platform enabling laboratories to efficiently evaluate data generated by high-throughput next-generation sequencing (NGS) technologies. The QIAGEN software quickly filters genetic variants in a secure, private cloud-based environment to identify variants most likely to cause disease, drawing upon the Ingenuity Knowledge Base.

MolecularHealth Partners with GATC Biotech for Genetic Sequencing Technology and Expertise

MolecularHealth announced a unique agreement with GATC Biotech. GATC Biotech will provide protocols, support and extensive training of MolecularHealth's laboratory staff. Additionally, MolecularHealth will use GATC Biotech's LIMS (Laboratory Information Management System) in its newly opened clinical lab. These contributions will complement MolecularHealth's next generation sequencing offerings and its proprietary TreatmentMAP(TM) oncology treatment decision support platform.

Similar Private Companies By Industry

Company Name Region
Abnova GmbH Europe
CellSystems Biotechnologie Vertrieb GmbH Europe
Lead Discovery Center GmbH Europe
Pharmycron Service GmbH Europe
European Molecular Biology Laboratory Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GATC Biotech AG, please visit www.gatc-biotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.